Studies on vaccination against bacillary dysentery. 1. Immunization of mice against experimental Shigella infection
- PMID: 5294178
- PMCID: PMC2555250
Studies on vaccination against bacillary dysentery. 1. Immunization of mice against experimental Shigella infection
Abstract
In the course of a series of experiments begun in 1954 a number of different killed vaccines prepared from Shigella flexneri 1 and 2a serotypes were tested for their immunogenicity after intraperitoneal administration in mice followed by challenge with virulent organisms of the same serotype; some live vaccines were also tested intraperitoneally or orally.Maintenance of the mice on Freter's regimen proved a reliable method of rendering them susceptible to intestinal infection with streptomycin-resistant shigellae.Two killed vaccines conferred good protection against intracerebral challenge, but neither live nor killed vaccines administered intraperitoneally protected against oral infection of mice maintained on Freter's regimen. However, oral administration of live vaccine did confer significant protection against homologous oral challenge, the degree of protection depending on the dose of vaccine.
Similar articles
-
Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial.Bull World Health Organ. 1965;32(5):647-55. Bull World Health Organ. 1965. PMID: 5294180 Free PMC article.
-
Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines.Bull World Health Organ. 1968;39(3):375-80. Bull World Health Organ. 1968. PMID: 5303905 Free PMC article.
-
Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.Bull World Health Organ. 1971;45(4):457-64. Bull World Health Organ. 1971. PMID: 4948417 Free PMC article. Clinical Trial.
-
A review of the current status of enteric vaccines.P N G Med J. 1995 Dec;38(4):325-31. P N G Med J. 1995. PMID: 9522876 Review.
-
Shigellosis: the current status of vaccine development.Curr Opin Infect Dis. 2008 Jun;21(3):313-8. doi: 10.1097/QCO.0b013e3282f88b92. Curr Opin Infect Dis. 2008. PMID: 18448978 Review.
Cited by
-
Investigation of oral immunization with streptomycin-dependent Escherichia coli.Folia Microbiol (Praha). 1972;17(2):153-6. doi: 10.1007/BF02877914. Folia Microbiol (Praha). 1972. PMID: 4552836 No abstract available.
-
Shigella-Controlled Human Infection Models: Current and Future Perspectives.Curr Top Microbiol Immunol. 2024;445:257-313. doi: 10.1007/82_2021_248. Curr Top Microbiol Immunol. 2024. PMID: 35616717 Free PMC article. Review.
-
Studies on vaccination against bacillary dysentery. 2. Safety tests and reactogenicity studies on a live dysentery vaccine intended for use in field trials.Bull World Health Organ. 1965;32(5):637-45. Bull World Health Organ. 1965. PMID: 5294179 Free PMC article.
-
Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans.Infect Immun. 2000 Mar;68(3):1034-9. doi: 10.1128/IAI.68.3.1034-1039.2000. Infect Immun. 2000. PMID: 10678904 Free PMC article.
-
From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review.Vaccines (Basel). 2022 Apr 20;10(5):645. doi: 10.3390/vaccines10050645. Vaccines (Basel). 2022. PMID: 35632401 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources